Clover Health stock holds near a 52-week high
Published on 09/02/2026 at 13:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Clover Health Investments, Corp. (CLOV) stock traded at USD 4.15 after a previous close of USD 4.15, with a market cap of USD 2.284 billion and a 52-week range of USD 1.58 to USD 5.59 as of September 2, 2026.
The latest catalyst is the companys Q2 2026 report: revenue reached USD 743.17 million, EPS came in at USD 0.05, and both figures beat the estimates of USD 728.27 million and USD 0.04, according to MarketBeat.
Q2 numbers set the tone
For investors, the comparison matters more than the headline beat: revenue was USD 743.17 million versus USD 728.27 million expected, a gap of USD 14.90 million, while EPS was USD 0.05 versus USD 0.04 expected.
MarketBeat also says the stock now carries a consensus Hold rating and a consensus price target of USD 4.33, a small premium to the latest trading level. That keeps the share price close to the middle of its yearly band rather than at the top of it.
Membership still drives revenue
Clovers business model still centers on Medicare Advantage plans, and that remains the key operating driver behind the Q2 2026 revenue base. The quarter also points to a business that is still scaling while the market remains focused on profitability and margins.
The companys earnings calendar on MarketBeat lists the next estimated earnings date as November 4, 2026, after the August 5, 2026 release for the second quarter.
More on CLOV and its latest quarter
The companys most recent quarter gives a clearer view of revenue momentum, estimate beats, and the valuation gap around the stock.
Medicare Advantage remains central
Clovers core product is still its Medicare Advantage offering, which is the business line that links membership trends to revenue and margin development. For a healthcare stock, that mix matters more than a simple revenue headline.
Stock level and range
Clover Health stock traded at USD 4.15 on September 2, 2026, with a 52-week range of USD 1.58 to USD 5.59 and a market cap of USD 2.284 billion.
Clover Health at a glance
- Company: Clover Health Investments, Corp.
- ISIN: US18914F1030
- Ticker: CLOV
- Trading venue: NASDAQ
- Price (as of September 2, 2026): USD 4.15
- Market capitalization: USD 2.284 billion (as of September 2, 2026)
- Sector / Industry: Health Care / Managed Health Care
- Index membership: None
- Next earnings date: November 4, 2026
